ECONOMIC AND CLINICAL OUTCOMES AMONG PATIENTS WITH ACUTE ISCHEMIC STROKE- A RETROSPECTIVE ANALYSIS OF US HOSPITAL DATABASE

Author(s)

Rai A1, Crivera C2, Kalsekar I3, Kumari R4, Patino N5, Chekani F3, Khanna R3
1West Virginia University, Morgantown, WV, USA, 2Johnson & Johnson Medical Device Business Services, Inc, Irvine, CA, USA, 3Johnson & Johnson Co., New Brunswick, NJ, USA, 4Mu Sigma Inc, Bangalore, India, 5Johnson & Johnson Co., New brunswick, NJ, USA

OBJECTIVES:

Stroke is one of the leading causes of morbidity and mortality among adults in the United States (US), with ~87% of stroke cases being acute ischemic stroke (AIS). This study evaluated trends in discharge status, mortality, length of stay (LOS), and 1-year all-cause readmission rate among patients with AIS.

METHODS:

Using Premier Healthcare Database, which includes discharge-level data from roughly 700 hospitals in the US, patients aged ≥18 years with an inpatient admission with a primary diagnosis (ICD-9-CM 433.xx, 434.xx, 436 and ICD-10-CM equivalents) of AIS were identified from January 1, 2011-September 30, 2017. The first admission during the study period was considered as index admission. Index admission outcomes including discharge status and mortality, and length of stay (LOS) were studied. One-year inpatient readmission rates were examined, with the limitation that readmissions in Premier database can only be assessed if patients are readmitted to the same hospital. Trends in outcomes were examined for significance using the Mann-Kendall test for trends.

RESULTS:

The final sample included 505,824 patients with AIS. The average age was 70 years. Almost half were female, and 69.5% were white. A significant decrease in mortality, from 3.86% in 2011 to 3.18% in 2017 (p<0.01) was observed among AIS patients. The average LOS among AIS patients also decreased significantly from 5.46 days in 2011 to 5.11 days 2017 (p<0.01). One-year all-cause inpatient readmission rates decreased significantly from 30.83% in 2011 to 27.40% in 2016Q3 (p<0.01).

CONCLUSIONS:

Significant improvements in mortality, LOS, and readmission rate were observed among AIS patients in our study. To what extent the outcomes improvement observed among AIS patients was contributed by the innovation in treatment modalities remains to be seen.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Value in Health, Vol. 21, S3 (October 2018)

Code

PMD128

Topic

Health Policy & Regulatory

Topic Subcategory

Pricing Policy & Schemes

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×